A new era in the treatment of primary pulmonary hypertension

Heart. 2001 Mar;85(3):251-2. doi: 10.1136/heart.85.3.251.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Antihypertensive Agents / therapeutic use*
  • Bosentan
  • Epoprostenol / therapeutic use*
  • Female
  • Genetic Therapy
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Hypertension, Pulmonary / etiology
  • Hypertension, Pulmonary / therapy
  • Nitric Oxide / therapeutic use
  • Sulfonamides / therapeutic use
  • Thromboxanes / therapeutic use
  • Vasodilator Agents / therapeutic use

Substances

  • Antihypertensive Agents
  • Sulfonamides
  • Thromboxanes
  • Vasodilator Agents
  • Nitric Oxide
  • Epoprostenol
  • Bosentan